Amends the definitions of diagnostic pharmaceuticals, topical therapeutic pharmaceutical agents, and therapeutic pharmaceutical agents for treatment of glaucoma and ocular hypertension as they relate to the certification to use therapeutic drugs in the practice of optometry.
Amends the definitions of diagnostic pharmaceuticals, topical therapeutic pharmaceutical agents, and therapeutic pharmaceutical agents for treatment of glaucoma and ocular hypertension as they relate to the certification to use therapeutic drugs in the practice of optometry.
Amends the definitions of diagnostic pharmaceuticals, topical therapeutic pharmaceutical agents, and therapeutic pharmaceutical agents for treatment of glaucoma and ocular hypertension as they relate to the certification to use therapeutic drugs in the practice of optometry.
Relating to the practice of therapeutic optometry.
Relating to the dispensing of aesthetic pharmaceuticals by physicians and therapeutic optometrists; imposing fees.
Relating to the practice of therapeutic optometry.
Relating to the dispensing of pharmaceuticals with an aesthetic purpose by physicians and therapeutic optometrists.
Relating to the dispensing of pharmaceuticals with an aesthetic purpose by physicians and therapeutic optometrists.
Relating to the dispensing of aesthetic pharmaceuticals by physicians and therapeutic optometrists; imposing fees.
Relating to the dispensing of aesthetic pharmaceuticals by physicians and therapeutic optometrists; imposing fees.